• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Effect of hemoperfusion on plasma oxidizing capacity and erythrocyte sensitivity to oxidation in patients with chronic uremia].

作者信息

Trznadel K, Luciak M, Mamczur D, Kroczak M, Zbróg Z, Kidawa Z

出版信息

Pol Tyg Lek. 1989 Feb 27;44(9):226-8.

PMID:2813185
Abstract

An effect of haemoperfusion on plasma oxidizing capacity and erythrocyte sensitivity to oxidation was investigated in patients with the chronic uremia. It was found that plasma oxidizing capacity measured with NTB reduction is more pronounced in patients with the chronic uremia than in normal subjects. Oxidizing capacity of plasma is increased at the beginning of haemoperfusion. This effect is clearly seen during single pass of blood through the column with activated carbon. Erythrocyte sensitivity to oxidation following their suspension in the normal saline with phosphate buffer and measured with ascorbic-cyanate test does not differ significantly in patients with the chronic uremia and healthy subjects and does not change markedly during haemoperfusion.

摘要

相似文献

1
[Effect of hemoperfusion on plasma oxidizing capacity and erythrocyte sensitivity to oxidation in patients with chronic uremia].
Pol Tyg Lek. 1989 Feb 27;44(9):226-8.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Hemoperfusion in chronic uremia.
Boll Soc Ital Biol Sper. 1993 Nov;69(11):675-82.
4
[Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].血液灌流对慢性尿毒症患者各种凝血及纤溶因子的影响
Pol Tyg Lek. 1981 Aug 31;36(35):1325-7.
5
[A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].[慢性尿毒症患者血液灌流与血液透析过程中血浆中、分子量分子及肌醇清除效率的比较]
Pol Tyg Lek. 1978 Feb 13;33(7):257-9.
6
Increased plasma oxidizability and decreased erythrocyte and plasma antioxidative capacity in patients with NIDDM.
Isr Med Assoc J. 1999 Dec;1(4):228-31.
7
Erythrocyte transport of middle molecular substances.
Proc Eur Dial Transplant Assoc. 1981;18:183-7.
8
Zinc tolerance tests in chronic uremia.慢性尿毒症患者的锌耐受性试验。
Clin Nephrol. 1981 Oct;16(4):181-7.
9
[Effects of metal-catalyzed oxidation on the formation of advanced oxidation protein products].[金属催化氧化对晚期氧化蛋白产物形成的影响]
Zhonghua Yi Xue Za Zhi. 2008 Mar 11;88(10):674-8.
10
Effect of haemoperfusion on the left ventricular systolic function in patients with chronic uraemia.血液灌流对慢性尿毒症患者左心室收缩功能的影响。
Acta Med Pol. 1981;22(1):75-9.